High dose Simvastatin has no beneficial effect on markers of bone turn-over in multiple myeloma

TE Søndergaard, PT Pedersen, TL Andersen, Thomas Lund, P Garnero, Jean-Marie Delaissé, Torben Plesner

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskning

OriginalsprogEngelsk
TidsskriftBlood
Udgave nummer4824
Sider (fra-til)280B
Antal sider280
ISSN0006-4971
StatusUdgivet - 2007
BegivenhedASH -
Varighed: 24. aug. 2010 → …
Konferencens nummer: 49

Konference

KonferenceASH
Nummer49
Periode24/08/2010 → …

Citer dette

Søndergaard, TE., Pedersen, PT., Andersen, TL., Lund, T., Garnero, P., Delaissé, J-M., & Plesner, T. (2007). High dose Simvastatin has no beneficial effect on markers of bone turn-over in multiple myeloma. Blood, (4824), 280B.
Søndergaard, TE ; Pedersen, PT ; Andersen, TL ; Lund, Thomas ; Garnero, P ; Delaissé, Jean-Marie ; Plesner, Torben. / High dose Simvastatin has no beneficial effect on markers of bone turn-over in multiple myeloma. I: Blood. 2007 ; Nr. 4824. s. 280B.
@article{f2159b60dacf11dc860c000ea68e967b,
title = "High dose Simvastatin has no beneficial effect on markers of bone turn-over in multiple myeloma",
author = "TE S{\o}ndergaard and PT Pedersen and TL Andersen and Thomas Lund and P Garnero and Jean-Marie Delaiss{\'e} and Torben Plesner",
year = "2007",
language = "English",
pages = "280B",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "4824",

}

Søndergaard, TE, Pedersen, PT, Andersen, TL, Lund, T, Garnero, P, Delaissé, J-M & Plesner, T 2007, 'High dose Simvastatin has no beneficial effect on markers of bone turn-over in multiple myeloma', Blood, nr. 4824, s. 280B.

High dose Simvastatin has no beneficial effect on markers of bone turn-over in multiple myeloma. / Søndergaard, TE; Pedersen, PT; Andersen, TL; Lund, Thomas; Garnero, P; Delaissé, Jean-Marie; Plesner, Torben.

I: Blood, Nr. 4824, 2007, s. 280B.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskning

TY - ABST

T1 - High dose Simvastatin has no beneficial effect on markers of bone turn-over in multiple myeloma

AU - Søndergaard, TE

AU - Pedersen, PT

AU - Andersen, TL

AU - Lund, Thomas

AU - Garnero, P

AU - Delaissé, Jean-Marie

AU - Plesner, Torben

PY - 2007

Y1 - 2007

M3 - Conference abstract in journal

SP - 280B

JO - Blood

JF - Blood

SN - 0006-4971

IS - 4824

ER -

Søndergaard TE, Pedersen PT, Andersen TL, Lund T, Garnero P, Delaissé J-M et al. High dose Simvastatin has no beneficial effect on markers of bone turn-over in multiple myeloma. Blood. 2007;(4824):280B.